Pharmacodynamic analysis of eribulin safety in breast cancer patients using real ‐world postmarketing surveillance data

Cancer Science, EarlyView.

Source: Cancer Science - July 24, 2018 Category: Cancer & Oncology Authors: Takahisa Kawamura , Hidefumi Kasai , Valentina Fermanelli , Toshiaki Takahashi , Yukinori Sakata , Toshiyuki Matsuoka , Mika Ishii , Yusuke Tanigawara Source Type: research